Targets › LAMC2
1 program from 1 company in 1 trial: 1 Phase 1; Other.
Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. Ladsin exerts cell-scattering activity toward a wide variety of cells, including epithelial, endothelial, and fibroblastic cells. (UniProt, Q13753)
Open in Phaseline: the race on LAMC2, likelihood bands and readouts
| Company | Drug | Targets | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|---|
| University of Southern California | Gentamicin Bacterial 70S ribosome inhibitor | LAMB3, LAMA3, LAMC2 | Phase 1 | Junctional Epidermolysis Bullosa | – |
Junctional Epidermolysis Bullosa (1)
small molecule (1)
Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.